Scopus Asset Management’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.73M Hold
40,000
0.07% 239
2026
Q1
$4.78M Sell
40,000
-10,000
-20% -$1.31M 0.08% 236
2025
Q4
$6.81M Sell
50,000
-30,000
-38% -$4.31M 0.11% 206
2025
Q3
$11.8M Buy
80,000
+30,800
+63% +$4.27M 0.16% 183
2025
Q2
$6.36M Sell
49,200
-800
-2% -$96.9K 0.11% 197
2025
Q1
$5.97M Sell
50,000
-20,000
-29% -$2.48M 0.12% 176
2024
Q4
$8.12M Hold
70,000
0.19% 134
2024
Q3
$9.45M Sell
70,000
-30,000
-30% -$4.01M 0.17% 167
2024
Q2
$13.6M Buy
+100,000
New +$13.6M 0.27% 117
2017
Q3
Sell
-200,000
Closed -$11.1M 363
2017
Q2
$11.1M Buy
+200,000
New +$10.4M 0.12% 166

Other funds holding XYL

Scopus Asset Management's XYL Position: Q2 2026 in Review

Scopus Asset Management sold out of Xylem (XYL) in Q2 2026, closing a stake of 148,245 shares — an estimated $17.1M sold.

Scopus Asset Management first reported a position in XYL in Q4 2015 and held it in 19 quarters. The position peaked at $30.1M in Q4 2017. 1,100 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Scopus Asset Management reported no remaining Xylem position as of Q2 2026 after selling out during the quarter.
  • Scopus Asset Management sold 148,245 Xylem shares in Q2 2026, an estimated $17.1M.
  • Scopus Asset Management first reported a position in Xylem in Q4 2015 and held it in 19 quarters.
  • Scopus Asset Management's Xylem position peaked at $30.1M in Q4 2017.
  • 1,100 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Scopus Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.